Diagnostic Accuracy of Teledermatology in Patch Test Interpretation

Teledermatology Clinical Trial

— Tele patch  

Official title:

Diagnostic Accuracy of Teledermatology in Patch Test Interpretation

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT06213545
• Other study ID #: COA 589/2566(IRB3)
• Status: Active, not recruiting
• Phase: N/A
• Start date: September 18, 2023
• Est. completion date: September 30, 2024

Study information

• Verified date: January 2024
• Source: Mahidol University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to learn about accuracy of teledermatology in patch test interpretation in patch test's patients population. The main question[s] it aims to answer are:

• Accuracy of teledermatology in patch test interpretation by dermatologist

• Accuracy of teledermatology in patch test interpretation by Residency

• Accuracy of teledermatology in patch test interpretation by Scitentist

• The factors influencing the interpretation of remote dermatologic patch test results from photographs of patients.

Participants will

• do patch test in Siriraj hospital and come to follow up at 48 hr and 72 hr for interpretation of patch test

• take a photo at home and sent the photo to contact clinic via online application or email on the day of 48 hr, 72 hr and 7 days following the interpretation of patch test

Researchers will compare in-clinic group and telephoto group to see if the accuracy of patch test interpretation is more or less.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 108
• Est. completion date: September 30, 2024
• Est. primary completion date: June 30, 2024
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participants in the study must be 18 years of age or older.

• Participants in the study must have undergone patch testing for contact allergies.

• Participants in the study should be able to take photos of test results on their back and/or arms using a mobile phone or personal camera, and send them to the researcher through the Line application and/or email within 48 hours, 96 hours, and on the 7th day.

• Participants in the study should be able to read and comprehend the questionnaire in Thai and respond to the questionnaire independently.

• Participants in the study must have at least one positive result in the patch testing.

• Participants in the study must provide consent to participate in the study by signing the informed consent document.

Exclusion Criteria:

• Participants in the study who are unable to attend follow-up appointments for result assessments.

Related Conditions & MeSH terms

• Teledermatology

Intervention

Diagnostic Test:
• In-clinic interpretation
Reading patch test result at clinic
• Photo interpretation
Reading patch test result by sending photo to clinic

Locations

Country	Name	City	State
Thailand	Faculty of medicine, Siriraj hospital, Mahidol university	Bangkoknoi	Bangkok

Sponsors (1)

Lead Sponsor	Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	grading of patch test	sucess, intermediate and failure	48 hours, 72 hours and 7 days